Abstract:Objective To observe the changes of tissue factor (TF) and tissue factor pathway inhibitor(TFPI) in patients with coronary heart disease. Methods 32 patients with acute myocardial infarction(AMI),27 patients with unstable angina pectoris(UAP),and 20 patients with stable angina pectoris(SAP) were studied.15 healthy volunteers served as control.Plasma TF and TFPI activities were measured with chromogenic assay. Results Plasma TF and TFPI activities were significantly higher in patients with AMI than those in control group and patients with SAP( P 0.05); there were no significant changes of plasma TF,compared with those of patients with UAP(P 0.05 ). Plasma TFPI activity was significantly higher in patients with AMI than those of patients with UAP (P 0.05). Plasma TF activity was significantly higher in patients with UAP than those in control group and patients with SAP (P 0.05), but there were no significant changes of plasma TFPI compared with those of controls and patients with SAP (P 0.05 ) .There were no statistical differences of TF and TFPI in patients with SAP compared with those of controls (P 0.05 ).Conclusion (1) There exists an abnormally activated hyper-coagulation state in patients with AMI and patients with UAP. TF is recognized as the initial trigger of the extrinsic coagulation pathway which play a critical role in the pathogenesis of coronary thrombosis.(2)The balance between TF and TFPI is deranged in patients with AMI or with UAP.

Changes of Plasma Tissue Factor and Pathway Inhibitor in Patients with Coronary Heart Disease